Garon EB, Spira AI, Goldberg SB, Chaft JE, et al. Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in PD-(L)1-Monotherapy Pretreated, Advanced Non-Small Cell Lung Cancer: Results From a Phase 1b Clinical Trial. J Thorac Oncol 2023 May 3:S1556-0864(23)00524.
PMID: 37146752